Literature DB >> 2015557

Primary anterior mediastinal B-cell lymphoma. A clinicopathologic and immunohistochemical study of 16 cases.

M al-Sharabati1, S Chittal, I Duga-Neulat, G Laurent, C Mazerolles, T al-Saati, P Brousset, G Delsol.   

Abstract

Sixteen cases of primary anterior mediastinal B-cell lymphoma were characterized by morphologic, immunophenotypic, and clinical profiles. Twelve were men and four were women. The median age was 42 years. Virtually all tumors were of large cell type. Three main morphologic categories were identified, with one rare exception. In some tumors, the cells were compatible with centrocytes and centroblasts (four). Others had cells readily identifiable as centroblasts (six). Both these groups had a variable proportion of cells with multilobed nuclei. A third group was composed mainly of unclassifiable cells with multilobed nuclei (five). All had discernible sclerosis of varying intensity. A wider range of morphologic features and different sex distribution was noticed in comparison with previously reported clear cell features and younger women. The dominant phenotype of these B-cell lymphomas was CD19+, CD22+, CD37+, CD21-, CD30-, CD10-, CD5-, and Ig-negative. The finding of CD21-, Ig-negative phenotype, as observed by the authors and others, overlaps with some high-grade lymphomas of follicular center cell origin but is thought to bear similarity to a noncirculating population of thymic medullary B-cells. The tumors attained large size without peripheral dissemination and responded to chemotherapy as well as radiotherapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015557     DOI: 10.1002/1097-0142(19910515)67:10<2579::aid-cncr2820671030>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patients.

Authors:  Ajay K Gopal; Stefano R Tarantolo; Naresh Bellam; Damian J Green; Melissa Griffin; Tatyana Feldman; Anthony R Mato; Amy J Eisenfeld; Scott C Stromatt; Andre Goy
Journal:  Invest New Drugs       Date:  2014-06-15       Impact factor: 3.850

2.  Primary mediastinal large B-cell lymphoma: a comparative study with nodular sclerosis-type Hodgkin's disease.

Authors:  N Yonetani; M Kurata; M Nishikori; H Haga; K Ohmori; H Yamabe; T Uchiyama; H Ohno
Journal:  Int J Hematol       Date:  2001-08       Impact factor: 2.490

3.  Molecular characterization of primary mediastinal B cell lymphoma.

Authors:  P Tsang; E Cesarman; A Chadburn; Y F Liu; D M Knowles
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

4.  Adhesion receptor profile of thymic B-cell lymphoma.

Authors:  A Eichelmann; K Koretz; G Mechtersheimer; P Möller
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

5.  Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas.

Authors:  P Kanavaros; P Gaulard; F Charlotte; N Martin; C Ducos; M Lebezu; D Y Mason
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

6.  Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.

Authors:  Stefano A Pileri; Gianluca Gaidano; Pier Luigi Zinzani; Brunangelo Falini; Philippe Gaulard; Emanuele Zucca; Federica Pieri; Eva Berra; Elena Sabattini; Stefano Ascani; Milena Piccioli; Peter W M Johnson; Roberto Giardini; Edoardo Pescarmona; Domenico Novero; Pier Paolo Piccaluga; Teresa Marafioti; Miguel A Alonso; Franco Cavalli
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

7.  Primary mediastinal lymphomas, their morphological features and comparative evaluation.

Authors:  Riti Aggarwal; Seema Rao; Shashi Dhawan; Sunita Bhalla; Arvind Kumar; Prem Chopra
Journal:  Lung India       Date:  2017 Jan-Feb

8.  Mediastinal large-cell lymphoma with sclerosis (MLCLS).

Authors:  A Z Rohatiner; J S Whelan; R K Ganjoo; A J Norton; A Wilson; T A Lister
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

9.  Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.

Authors:  G Todeschini; S Secchi; E Morra; U Vitolo; E Orlandi; F Pasini; E Gallo; A Ambrosetti; C Tecchio; C Tarella; A Gabbas; A Gallamini; L Gargantini; M Pizzuti; G Fioritoni; L Gottin; G Rossi; M Lazzarino; F Menestrina; M Paulli; M Palestro; M G Cabras; F Di Vito; G Pizzolo
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.